Nutriband Inc. (NASDAQ: NTRB) announced that its wholly owned subsidiary, Active Intelligence, will participate in the June 2026 ECRM conference. The company plans to showcase its expanding portfolio of wellness, recovery, and performance-focused consumer products to buyers from major retail, pharmacy, and healthcare organizations. Active Intelligence will feature its existing AI Tape line and introduce new products including AI Performance Tape, AI Energy Patches, and AI Sleep as it seeks to expand retail partnerships and distribution opportunities.
The ECRM conference provides a platform for suppliers to meet with key decision-makers from retailers and distributors. For Nutriband, this event represents an opportunity to gain shelf space in major outlets for its consumer health products. The company's strategy involves leveraging its transdermal technology expertise to enter the wellness market, which is a growing segment. The new products, such as AI Energy Patches and AI Sleep, target consumers looking for non-pharmaceutical solutions for energy and sleep support.
Nutriband is primarily engaged in developing a portfolio of transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating its AVERSA technology. The AVERSA technology can be incorporated into any transdermal patch to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. The company's website is www.nutriband.com.
The announcement comes as Nutriband continues to diversify its product offerings beyond prescription pharmaceuticals. By entering the consumer wellness space, the company aims to generate revenue from over-the-counter products while advancing its core pharmaceutical pipeline. The success of this strategy will depend on securing retail partnerships and consumer adoption of the new product lines.
For more information on Nutriband, the latest news and updates are available in the company’s newsroom at https://ibn.fm/NTRB.
